EMR showing upside potential
Emerson is half way into the cycle with price target ranging from $93 to $96. I expect earnings to be good, but the recent indication for a hostile acquisition might overshadow the ER. I believe this will trend in a range until mid March when this could start its next leg up.
Disclaimer: My opinion on stocks are mine alone and not to be taken as Investment advice.
Disclaimer: My opinion on stocks are mine alone and not to be taken as Investment advice.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。